Skip to content
SHORLA PHARMA
  • About Us
    • Our Vision
    • Our Purpose
    • Our Values
  • Our Team
  • Products
    • SH-105
    • SH-110
    • SH-111
  • News
  • Contact

News

John Moloney and Tracy Woody announced as non-executive Board members

December 21st 2020November 10th 2020

Read More

Shorla speak with Dr. Scott Gottlieb, 23rd FDA Commissioner

October 9th 2020October 9th 2020

Read More

SH-110 Successful FDA Pre-IND Meeting

October 2nd 2020October 2nd 2020

Read More

Shorla Pharma named Local Enterprise of the Year at The Irish Times Business Awards 2020

September 3rd 2020September 3rd 2020

Read More

Shorla Pharma closes $8.3M Series A funding round

June 6th 2020June 6th 2020

Read More

Manufacture of first GMP batch of SH-111

September 2nd 2020May 11th 2020

Read More

University City Science Center Bootcamp, Philadelphia, USA

May 27th 2020February 14th 2020

Read More

Worldwide Association of MBA’s Best Entrepreneurial Venture Award (Private Sector) 2020

May 14th 2020February 7th 2020

Read More

J.P. Morgan Annual Healthcare Conference, San Francisco, USA

May 1st 2020January 10th 2020

Read More

Post navigation
Older posts
1 2 3

HEAD OFFICE:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

US OFFICE:
345 Park Ave,
New York,
NY 10154,
USA

SITEMAP
PRIVACY POLICY
Company number: 618033

©SHORLA PHARMA 2021
© 2021 SHORLA PHARMA • Powered by GeneratePress
  • About Us
    • Our Vision
    • Our Purpose
    • Our Values
  • Our Team
  • Products
    • SH-105
    • SH-110
    • SH-111
  • News
  • Contact